Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brain, behavior, and immunity

• Publication date

  2016-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.bbi.2016.02.005PMID 26872421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

  2016cited by this paper
• Circulating anti-brain autoantibodies in schizophrenia and mood disorders.

  2015cited by this paper
• Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment.

  2015cited by this paper
• Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications

  2015cited by this paper
• Role of T helper lymphokines in the immune-inflammatory pathophysiology of schizophrenia: Systematic review and meta-analysis

  2015cited by this paper
• Robust enumeration of cell subsets from tissue expression profiles

  2015cited by this paper
• An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples

  2015cited by this paper
• Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses.

  2015cited by this paper
• Discordant CD34+ cell results in peripheral blood and hematopoietic progenitor cell–apheresis product: implications for clinical decisions and impact on patient treatment

  2014cited by this paper
• Informed consent in psychiatric research - concepts and challenges.

  2014cited by this paper
• Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils

  2014cited by this paper
• Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia

  2014cited by this paper
• Building Bivariate Tables: The compareGroups Package for R

  2014cited by this paper
• Role of Circulating Lymphocytes in Patients with Sepsis

  2014cited by this paper
• Getting nervous about immunity.

  2014cited by this paper
• Dopamine Inhibits the Effector Functions of Activated NK Cells via the Upregulation of the D5 Receptor

  2014cited by this paper
• Long-term storage of blood RNA collected in RNA stabilizing Tempus tubes in a large biobank – evaluation of RNA quality and stability

  2014cited by this paper
• Monocyte and Lymphocyte Activation in Bipolar Disorder: A New Piece in the Puzzle of Immune Dysfunction in Mood Disorders

  2014cited by this paper
• Elevated neutrophil/lymphocyte ratio in patients with schizophrenia.

  2014cited by this paper
• High salt buffer improves integrity of RNA after fluorescence-activated cell sorting of intracellular labeled cells.

  2014cited by this paper
• Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis.

  2013cited by this paper
• Computational deconvolution: extracting cell type-specific information from heterogeneous samples.

  2013cited by this paper
• Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder.

  2013cited by this paper
• Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile

  2013influential reference
• CellMix: a comprehensive toolbox for gene expression deconvolution

  2013cited by this paper
• Digital sorting of complex tissues for cell type-specific gene expression profiles

  2013cited by this paper
• Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia.

  2013cited by this paper
• Dopamine Receptors Modulate Cytotoxicity of Natural Killer Cells via cAMP-PKA-CREB Signaling Pathway

  2013cited by this paper
• Monitoring of Technical Variation in Quantitative High-Throughput Datasets

  2013cited by this paper
• Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

  2013cited by this paper
• Quantitation of Gene Expression in Formaldehyde-Fixed and Fluorescence-Activated Sorted Cells

  2013cited by this paper
• Can bipolar disorder be viewed as a multi-system inflammatory disease?

  2012cited by this paper
• Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease

  2012cited by this paper
• Methamphetamine Administration Targets Multiple Immune Subsets and Induces Phenotypic Alterations Suggestive of Immunosuppression

  2012cited by this paper
• AffyRNADegradation: control and correction of RNA quality effects in GeneChip expression data

  2012cited by this paper
• NCBI GEO: archive for functional genomics data sets—update

  2012cited by this paper
• Estimating RNA-quality using GeneChip microarrays

  2012influential reference
• Strategies for aggregating gene expression data: The collapseRows R function

  2011cited by this paper
• The activation of monocyte and T cell networks in patients with bipolar disorder.

  2011cited by this paper
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cited by this paper
• Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity

  2010cited by this paper
• Cell type–specific gene expression differences in complex tissues

  2010cited by this paper
• Cocaine administration increases CD4/CD8 lymphocyte ratio in peripheral blood despite lymphopenia and elevated corticosterone.

  2010cited by this paper
• Deconvolution of Blood Microarray Data Identifies Cellular Activation Patterns in Systemic Lupus Erythematosus

  2009cited by this paper
• The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.

  2009cited by this paper
• CD56bright natural killer (NK) cells: an important NK cell subset

  2009cited by this paper
• Natural killer cells of Parkinson's disease patients are set up for activation: a possible role for innate immunity in the pathogenesis of this disease.

  2008cited by this paper
• Psychoneuroimmunology – Cross-talk between the immune and nervous systems

  2007cited by this paper
• Adjusting batch effects in microarray expression data using empirical Bayes methods.

  2007cited by this paper
• Immunological changes in patients with mania: changes in cell mediated immunity in a sample from Egyptian patients.

  2006cited by this paper
• Altered levels of acute phase proteins in the plasma of patients with schizophrenia.

  2006cited by this paper
• A false expression of CD8 antigens on CD4+ T cells in a routine flow cytometry analysis.

  2006cited by this paper
• Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

  2005cited by this paper
• Search for atypical lymphocytes in schizophrenia

  2004cited by this paper
• affy - analysis of Affymetrix GeneChip data at the probe level

  2004cited by this paper
• Lymphocytes in schizophrenic patients under therapy: serological, morphological and cell subset findings.

  2004cited by this paper
• A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia.

  2003cited by this paper
• The influence of olanzapine on immune cells in patients with schizophrenia.

  2003cited by this paper
• High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder.

  2003cited by this paper
• Autonomic innervation of immune organs and neuroimmune modulation.

  2003cited by this paper
• Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study.

  2002cited by this paper
• In vitro study of monocyte viability during the initial adhesion to albumin- and fibrinogen-coated surfaces.

  2001cited by this paper
• T-helper-1 and T-helper-2 responses in psychiatric disorders.

  2001cited by this paper
• Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking.

  2000cited by this paper
• T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients.

  1999cited by this paper
• Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs.

  1997cited by this paper
• No evidence for autoimmunity in schizophrenia.

  1996cited by this paper
• Changes of immunological functions after acute exacerbation in schizophrenia.

  1994cited by this paper
• SUPPLEMENTARY NOTE

  1879influential reference

• A Comprehensive Analysis of Inflammation Regulatory Biomarkers among three Neuropsychiatric Disorders using Transcriptomic Approach

  2026cites this paper
• Peripheral and central innate immune alterations in schizophrenia and bipolar disorder: a systematic review of NK cells, monocytes and macrophages

  2025influential citation
• Psychoneuroimmunology of Mood Disorders.

  2025cites this paper
• Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?

  2024cites this paper
• Impact of second-generation antipsychotics monotherapy or combined therapy in cytokine, lymphocyte subtype, and thyroid antibodies for schizophrenia: a retrospective study

  2024cites this paper
• Coping styles do not interact with the association between childhood trauma history and the immune-inflammatory phenotype of schizophrenia: Findings from a cross-sectional study.

  2024cites this paper
• Natural killer (NK) cells in bipolar disorders

  2024cites this paper
• Inflammation and Mental Health Disorders: Immunomodulation as a Potential Therapy for Psychiatric Conditions.

  2023cites this paper
• Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil

  2023cites this paper
• Microglia and Other Cellular Mediators of Immunological Dysfunction in Schizophrenia: A Narrative Synthesis of Clinical Findings

  2023cites this paper
• CD 4+, CD 8+ and CD 19+cell surface antigen and abnormal mitochondria ultrastructure of peripheral blood P-type atypical lymphocytes in patients with schizophrenia

  2022cites this paper
• Neuroimmune pathways in bipolar disorder

  2022cites this paper
• Intestinal Microbes in Patients With Schizophrenia Undergoing Short-Term Treatment: Core Species Identification Based on Co-Occurrence Networks and Regression Analysis

  2022cites this paper
• Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy

  2021cites this paper
• Natural killer cells in first-episode psychosis: an innate immune signature?

  2021cites this paper
• Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis.

  2021cites this paper
• Pediatric Acute-Onset Neuropsychiatric Syndrome: A Data Mining Approach to a Very Specific Constellation of Clinical Variables

  2020cites this paper
• Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms.

  2020cites this paper
• Acutely Ill Psychiatric Inpatients and Antimicrobial Exposure

  2020cites this paper
• Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia

  2020cites this paper
• Genetic and environmental influences on circulating NK and T cells and their relation to bipolar disorder

  2019cites this paper
• First-episode schizophrenia is associated with a reduction of HERV-K methylation in peripheral blood.

  2019cites this paper
• 120th Anniversary of the Kraepelinian Dichotomy of Psychiatric Disorders

  2019cites this paper
• Natural Killer cells protect white matter integrity in Bipolar Disorder.

  2019cites this paper
• Transposable Elements and Their Epigenetic Regulation in Mental Disorders: Current Evidence in the Field

  2019cites this paper
• Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia

  2019cites this paper
• Inflammation in CNS neurodegenerative diseases

  2018cites this paper
• A Review of Neutrophil-Lymphocyte, MonocyteLymphocyte, and Platelet-Lymphocyte Ratios Use in Psychiatric Disorders

  2018cites this paper
• Further evidence for depletion of peripheral blood natural killer cells in patients with schizophrenia: A computational deconvolution study.

  2018cites this paper
• High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters

  2018cites this paper
• Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations

  2017cites this paper
• Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays

  2017cites this paper
• Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review.

  2017cites this paper
• Neutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar disorder

  2017cites this paper
• High-throughput genomic profiling of tumor-infiltrating leukocytes.

  2016cites this paper
• Reproducible Computational Workflows with Continuous Analysis

  2016cites this paper
• Expanding the Immunology Toolbox: Embracing Public-Data Reuse and Crowdsourcing.

  2016cites this paper